Supplement: Coriell: Banking on Cells

Coriell: Banking on Cells By Kathryn Ward Michael Christman In the late 1940s, a medical doctor and scientist used cell cultures to help bring the Salk polio vaccine to the public. Impressed with his work, business leaders in the Greater Philadelphia region enabled him to establish a basic research facility in 1953. The man was Lewis Coriell. The facility is the Coriell Institute for Medical Research, which today is an internationally known, independent, nonprofit biom

Written byKathryn Ward
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the late 1940s, a medical doctor and scientist used cell cultures to help bring the Salk polio vaccine to the public. Impressed with his work, business leaders in the Greater Philadelphia region enabled him to establish a basic research facility in 1953. The man was Lewis Coriell. The facility is the Coriell Institute for Medical Research, which today is an internationally known, independent, nonprofit biomedical research organization dedicated to understanding human genetic diseases and providing high-quality genetic resources.

A Region Defined

A Robust Support Infrastructure

The infrastructure

ECRI

Laureate Pharma

Quest Pharmaceutical

Immunicon

Fox Chase Cancer Center

Morgan, Lewis & Bockius

Covance

Paragon Chemical

InstaMed

Coriell occupies a new five-story laboratory facility on the campus of the University of Medicine and Dentistry of New Jersey. Located across the Delaware River from Philadelphia and Coriell serves the scientific community by maintaining a repository of the world's largest collection of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies